All Articles

Bolt's new network-based identity system uses device verification to fight rampant synthetic fraud, promising safer e-commerce for merchants and shoppers.

New federal rules make banking cheaper and more accessible for millions, especially newcomers, Indigenous peoples, and those with disabilities. Here's how.

A new DoD-funded study will test an AI-powered oxygen system in ambulances, promising to save lives on the battlefield and in civilian emergencies.

Biodexa Pharmaceuticals expands its pivotal Phase 3 trial for eRapa into Europe, a key step in tapping a $7B market for a rare cancer-causing disease.

Akamai's acquisition of WebAssembly leader Fermyon signals a major shift, promising faster, cheaper, and more secure AI for logistics and manufacturing.

With a key Wyoming project near production, U.S. Gold Corp. heads to a top London conference, a strategic play on domestic resources in a volatile world.

After a crushing trial failure, Neuphoria Therapeutics faces an activist investor's siege. This is the inside story of a proxy war for a biotech's soul.

Plug Power's new NASA contract is more than a space deal. It’s a test case for resilient supply chains with profound implications for critical industries.

Two 23-year-olds from rural France raised $4.1M after their AI beat Google DeepMind. Their goal: to fix the mobile industry's biggest bottleneck.

An OTC firm is launching an AI division with a radical promise: hit a revenue target and it becomes a new public company for existing shareholders.

Hadron Energy unveils an all-star board for its $1.2B public listing, betting its micro-nuclear reactors can solve the AI industry's energy crisis.

With Canada's first natural hydrogen well at a critical juncture, MAX Power installs a clean energy veteran to shift from pure exploration to production.

Coveo's new RAG-as-a-Service for AWS aims to fix AI's 'hallucination' and security issues, unlocking enterprise value and reshaping the cloud AI market.

With a new VP and a unique bank-powered platform, Cornerstone Capital Bank aims to capture market share amidst complex regulations and a shifting economy.

A UK-US team has unlocked a scalable method to create nuclear fuel from americium, paving the way for long-duration missions to the Moon and deep space.

With FDA alignment on a biomarker-driven trial, Cognition's zervimesine aims to reshape Alzheimer's treatment with a convenient, targeted oral therapy.

Facing financial headwinds, Treasure Global projects explosive growth through a high-stakes pivot into fintech. Can this strategic gamble pay off?

Medtech firm Kestra Medical seeks new capital to scale its wearable defibrillator, signaling a major push in the competitive cardiovascular tech market.

Teramind’s new AI co-pilot replaces security dashboards with simple Slack chats. This isn't just an update; it's a new era for managing insider risk.

A new antisense therapy, zorevunersen, shows disease-modifying potential, shifting focus from seizure control to tackling the genetic root of the disease.